OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

Renehan A.; Muirhead R.; McParland L.; Gilbert D.; Adams R.; Harrison M.; Hawkins M.; Sebag-Montefiore D.

首页> 外文期刊>Diseases of the Colon and Rectum >OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

【24h】

OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

机译：优化放疗剂量与化疗结合肛门癌 - 跨区域风险谱（柏拉图试验）的三种临床试验（包括外科手术行为3）的发展。

获取原文

获取原文并翻译 | 示例

开具论文收录证明 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Diseases of the Colon and Rectum》 |2017年第6期|共2页
作者
Renehan A.; Muirhead R.; McParland L.; Gilbert D.; Adams R.; Harrison M.; Hawkins M.; Sebag-Montefiore D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
专利

1. OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL). [J] . Renehan A., Muirhead R., McParland L., Diseases of the Colon and Rectum . 2017,第6期

机译：优化放疗剂量与化疗结合肛门癌 - 跨区域风险谱（柏拉图试验）的三种临床试验（包括外科手术行为3）的发展。
2. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and G [J] . Bartelink H, Roelofsen F, Eschwege F, Journal of Clinical Oncology . 1997,第5期

机译：在局部晚期肛门癌的治疗中，伴随放疗和化疗优于单纯放疗：欧洲癌症放疗和治疗研究与治疗组织III期随机试验的结果
3. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses [J] . Park Se Hoon, Sohn Tae Sung, Lee Jeeyun, Journal of Clinical Oncology . 2015,第28期

机译：III期试验比较胃癌中卡培他滨和顺铂与同时放化疗的辅助化学疗法：胃肿瘤试验中辅助放化疗的最终报告，包括生存率和亚组分析
4. Derivation and representation of dose-volume response from large clinical trial data sets: an example from the RADAR prostate radiotherapy trial [C] . MA Ebert, K Foo, A Haworth, ICCR . 2014

机译：来自大型临床试验数据组的剂量响应的衍生和表示：雷达前列腺放射治疗试验的一个例子
5. Bayesian dose-finding methods for cancer clinical trials in the era of precision medicine [D] . 加倉井　靖之 2019

机译：精确医学时代用于癌症临床试验的贝叶斯剂量寻找方法
6. Phase I trial of split-dose induction docetaxel cisplatin and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1) [O] . Katrin Oertel, Karin Spiegel, Harald Schmalenberg, 2012

机译：局部晚期口腔和口咽鳞状细胞癌（TISOC-1）患者的分剂量诱导多西他赛顺铂和5-氟尿嘧啶（TPF）化疗+根治性手术联合术后放疗的I期试验
7. Pre-specified pilot analysis of a randomised pilot/phase II/III trial comparing standard dose vs dose-escalated concurrent chemoradiotherapy (CRT) in anal cancer (PLATO-ACT5) [O] . A. Gilbert, L. McParland, J. Webster, 2019

机译：随机试验/期III / III试验预先指定的导频分析比较标准剂量对肛门癌中的标准剂量与剂量升级的同时化学疗法（CRT）（柏拉图 - ACT5）

OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

著录项

引文网络

相似文献

相关主题

期刊订阅